Smith & Nephew PLC SN.-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 04/19/24 BST
961.80quote price arrow down-5.00 (-0.52%)
52 week range
887.00 - 1,316.75
Loading...
  • Open960.20
  • Day High965.60
  • Day Low954.00
  • Prev Close966.80
  • 52 Week High1,316.75
  • 52 Week High Date05/02/23
  • 52 Week Low887.00
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap10,465.89M
  • Shares Out874.33M
  • 10 Day Average Volume4.31M
  • Dividend30.13
  • Dividend Yield3.13%
  • Beta0.82
  • YTD % Change-10.82

KEY STATS

  • Open960.20
  • Day High965.60
  • Day Low954.00
  • Prev Close966.80
  • 52 Week High1,316.75
  • 52 Week High Date05/02/23
  • 52 Week Low887.00
  • 52 Week Low Date10/27/23
  • Market Cap10,465.89M
  • Shares Out874.33M
  • 10 Day Average Volume4.31M
  • Dividend30.13
  • Dividend Yield3.13%
  • Beta0.82
  • YTD % Change-10.82

RATIOS/PROFITABILITY

  • EPS (TTM)23.70
  • P/E (TTM)40.58
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/28/2024
  • Div Amount23.10
  • Split Date-
  • Split Factor-

Latest On Smith & Nephew PLC

 

Profile

MORE
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and...
Rupert Soames OBE
Non-Executive Independent Chairman of the Board
Deepak Nath
Chief Executive Officer, Executive Director
John Rogers
Chief Financial Officer, Executive Director
Helen Barraclough
Group General Counsel, Company Secretary
Address
Building 5, Croxley Park, Hatters Lane
Watford
WD18 8YE
United Kingdom